Michael Nissen, Angel Investor

Michael Nissen is a Partner at ExSight Ventures and serves as Assistant Clinical Professor of Ophthalmology at Weill Cornell/New York Presbyterian Hospital. He holds an MD from Albany Medical College and a BA in English Literature from Middlebury College, reflecting a blend of medical expertise and broad academic grounding. As an angel investor, Nissen has invested in DefEYE, a seed-stage company valued at $12M. This investment highlights his interest in supporting ventures at the intersection of ophthalmology and advanced medical technology.